ストックスクリーナーアプリを入手
14.19
0.91%
-0.13
アフターアワーズ：
13.90
-0.29
-2.04%
前日終値:
$14.32
開ける：
$14.31
24時間の取引高:
436.95K
Relative Volume:
0.30
時価総額：
$384.22M
収益：
-
当期純損益:
$-49.81M
株価収益率:
-6.5816
EPS:
-2.156
ネットキャッシュフロー:
$-42.93M
1週間 パフォーマンス:
+29.00%
1か月 パフォーマンス:
+252.99%
6か月 パフォーマンス:
+469.88%
1年 パフォーマンス:
+264.78%
1日の値動き範囲:
$13.53
$14.70
1週間の範囲:
$11.23
$15.18
52週間の値動き範囲:
$1.60
$15.18
Alto Neuroscience Inc Stock (ANRO) Company Profile
名前
Alto Neuroscience Inc
セクター
電話
773-255-5012
住所
650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW
ANRO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ANRO
Alto Neuroscience Inc
|
14.19 | 442.62M | 0 | -49.81M | -42.93M | -2.156 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Alto Neuroscience Inc Stock (ANRO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-29 | 開始されました | Chardan Capital Markets | Buy |
| 2024-10-23 | ダウングレード | Rodman & Renshaw | Buy → Neutral |
| 2024-10-23 | ダウングレード | Wedbush | Outperform → Neutral |
| 2024-09-03 | 開始されました | Wedbush | Outperform |
| 2024-02-27 | 開始されました | Jefferies | Buy |
| 2024-02-27 | 開始されました | Robert W. Baird | Outperform |
| 2024-02-27 | 開始されました | Stifel | Buy |
| 2024-02-27 | 開始されました | TD Cowen | Outperform |
| 2024-02-27 | 開始されました | William Blair | Outperform |
すべてを表示
Alto Neuroscience Inc (ANRO) 最新ニュース
Can Alto Neuroscience Inc. hit a new high this month2025 Market Overview & Low Drawdown Momentum Ideas - newser.com
Chart based exit strategy for Alto Neuroscience Inc.Market Weekly Review & Fast Moving Market Watchlists - newser.com
Alto Neuroscience, Inc. (NYSE:ANRO) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Will Alto Neuroscience Inc. stock recover faster than marketStock Surge & Scalable Portfolio Growth Ideas - newser.com
Can Alto Neuroscience Inc. stock test all time highs2025 Top Decliners & Technical Pattern Recognition Alerts - newser.com
What data driven models say about Alto Neuroscience Inc.’s futureMarket Risk Summary & Daily Profit Focused Screening - newser.com
What the charts say about Alto Neuroscience Inc. todayDollar Strength & Real-Time Buy Signal Alerts - newser.com
Can Alto Neuroscience Inc. stock sustain free cash flow growth2025 Performance Recap & Free Technical Confirmation Trade Alerts - newser.com
What indicators show strength in Alto Neuroscience Inc.2025 Retail Activity & Stock Market Timing Techniques - newser.com
What makes Alto Neuroscience Inc. stock attractive to growth funds2025 Major Catalysts & Technical Entry and Exit Tips - newser.com
COMMODORE CAPITAL LP Acquires Significant Stake in Alto Neuroscience Inc - GuruFocus
Relative strength of Alto Neuroscience Inc. in sector analysisWeekly Trend Summary & Free Technical Confirmation Trade Alerts - newser.com
Will Alto Neuroscience Inc. stock maintain growth storyMarket Performance Report & Daily Market Momentum Tracking - newser.com
Is Alto Neuroscience Inc. trending in predictive chart modelsWatch List & Daily Stock Trend Watchlist - newser.com
How risky is Alto Neuroscience Inc. stock now2025 Historical Comparison & Risk Adjusted Buy and Sell Alerts - newser.com
How to track smart money flows in Alto Neuroscience Inc.Trade Volume Summary & Verified Swing Trading Watchlist - newser.com
Why retail investors pile into Alto Neuroscience Inc. stock2025 Institutional Moves & Consistent Growth Stock Picks - newser.com
Will Alto Neuroscience Inc. stock go up soon2025 Risk Factors & Daily Profit Maximizing Tips - newser.com
What institutional flow reveals about Alto Neuroscience Inc.Weekly Trade Report & Safe Capital Growth Plans - newser.com
Can Alto Neuroscience Inc. stock outperform in 2025 bull marketJuly 2025 Final Week & Weekly Top Performers Watchlists - newser.com
Risk adjusted return profile for Alto Neuroscience Inc. analyzedJuly 2025 Analyst Calls & Weekly High Momentum Picks - newser.com
Why institutional investors increase stakes in Alto Neuroscience Inc. stockJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Why Alto Neuroscience Inc. stock gets analyst attentionTrade Risk Report & Growth Oriented Trade Recommendations - newser.com
What market sentiment indicators show for Alto Neuroscience Inc. stockWeekly Trend Recap & AI Driven Price Predictions - newser.com
What MACD signals say about Alto Neuroscience Inc.2025 Market Outlook & Community Supported Trade Ideas - newser.com
Volume spikes in Alto Neuroscience Inc. stock – what they mean2025 Historical Comparison & Stock Market Timing Techniques - newser.com
Alto Neuroscience’s ALTO-100 Study: A Potential Game-Changer for Bipolar Disorder Treatment? - TipRanks
Biotech to Fast Track Phase 3 Depression Trial - streetwisereports.com
Buy Recommendation for Alto Neuroscience Driven by Promising ALTO-207 Acquisition and Strategic Financial Backing - TipRanks
Is Alto Neuroscience Inc. stock cheap compared to fundamentalsEarnings Overview Summary & Advanced Technical Signal Analysis - newser.com
Alto Neuroscience’s ALTO-101 Study: A Potential Game-Changer for Schizophrenia Treatment? - MSN
How Alto Neuroscience Inc. stock performs in volatility spikesMarket Activity Recap & Weekly Momentum Picks - newser.com
Alto Neuroscience Inc (ANRO) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):